views
![faruqi and faruqi alerts organogenesis shareholders](https://fortunetelleroracle.com/business/public/index.php/upload/media/posts/2022-06/06/faruqi-and-faruqi-alerts-organogenesis-shareholders_1654547239-b.jpg)
The Faruqi Securities Litigation Attorney James (Josh) Wilson Encourages those who have suffered losses of more than $50,000 In Organogenesis To Contact him directly to discuss their Options
New York, New York--(Newsfile Corp. - - October 24, 2021) -- Faruqi & Faruqi, LLP, a prominent national securities law firm, is investigating potential allegations against Organogenesis ("Organogenesis Holdings Inc." (or the "Company") (NASDAQ: ORGO).
If you've suffered losses that exceed $50,000 when you invested in Organogenesis stock or options and would like to discuss your rights under the law, contact Faruqi & Faruqi partner Josh Wilson directly at 877-247-492 or 212-983-9330 (Ext. 1310). You may also click here for additional https://www.linkedin.com information: http://www.faruqilaw.com/ORGO.
Faruqi & Faruqi is a top minority and women-owned national securities law firm with locations located in New York, Delaware, Pennsylvania, California and Georgia.
On the 12th of October, 2021 Value Investors Club issued an article exposing problems at Organogenesis Holdings, Inc. The report reveals that the wound care medical company has been improperly billing the federal government for $250 million per year. The Company additionally set the cost for its latest wound-covering, Affinity "exorbitantly high", which Medicare reimbursed, while making the product lucrative for doctors to purchase with large rebates.
In the wake of this, the price has fallen $1.70